PACB
PACIFIC BIOSCIENCES OF CALIFData as of 2026 Q2 (06-30) · 13F snapshot
Summary
PACIFIC BIOSCIENCES OF CALIF (PACB) is held as common stock by 8 tracked hedge-fund managers, with a combined reported value of ~$74.00M; the largest are Cathie Wood, Steven Cohen, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 2 added, 3 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Mixed
Common-stock holders81 also report options
Congress trades0
Price$1.71vs quarter-end+1.79%
Sectors0
This quarter's moves
Top holderNew1
Added2
Trimmed / sold3
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Cathie WoodTrim
Value $50.03M0.3% of portfolio29,781,4162026 Q2
Zhang LeiHold
Value $1.54M0.2% of portfolio918,8922026 Q2
Paul Tudor JonesHold
Value $1.15M0.0% of portfolio684,7072026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Cathie Wood | $50.03M | 0.3% | Trim |
| Zhang Lei | $1.54M | 0.2% | Hold |
| Paul Tudor Jones | $1.15M | 0.0% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $186.1K— of portfolio110,8002026 Q2
Value $109.5K— of portfolio65,2002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $186.1K | — | — |
| Ken GriffinPUT | $109.5K | — | — |
ARK ETF holdings
Cathie Wood · dailyARK total shares held · drag to inspect
2026-09-29holds 26,452,377
- ARKGweight in fund0.84%$18.38M
- ARKKweight in fund0.31%$26.85M
ARK publishes full ETF holdings daily (SEC Rule 6c-11). Line shows ARK's total shares held over time (not price); markers are buy/sell days. Derived from public CSVs — research only, not investment advice.
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.